aTyr Pharma (LIFE) to Offer Common Stock

aTyr Pharma, Inc. (Nasdaq: LIFE) announced that it has commenced an underwritten public offering of shares of its common stock. In addition, aTyr expects to grant the underwriters a 30-day option to purchase additional shares of its common stock. All of the shares to be sold in the offering are to be sold by aTyr. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.

Piper Sandler and RBC Capital Markets are acting as joint book-running managers for the offering.

You May Also Be Interested In

• AEVEX prices public offering of 8 million shares at $27 each
• TETRA Technologies prices public offering at $9.25 per share
• Pershing Square Selling About 80.6m Shares In Universal Music - Bloomberg